Skip to content

Han B. Kang, MD

NPI 1730767443ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Humble, TX

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Humble, Texas, licensed in TX, with an NPI issued in April 2021. Part D covered 359 prescriptions written in 2024, 68% of them generic. Corcept Therapeutics was the largest of 2 companies reporting payments in 2025, $51.87 in all, mostly food and beverage.

Overview

NPI1730767443
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedApr 1, 2021
Last updated in NPPESNov 2, 2026
Certified by providerNov 2, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (TX)

Part D prescriptions in 2024

Prescriptions (claims)359 · 725 30-day fills
Patients124
Total drug cost$92,983
Generic share68% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$51.87 · 2 payments from 2 companies
  • 2024$20.77 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Corcept Therapeutics$30.431
Kyowa Kirin, Inc.$21.441

What the 2025 payments were for

  • Food and Beverage$51.87 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Humble

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Texas →